Nevertheless, a recent study reported that combined genetic deletion of receptor-interacting serine/threonine-protein kinase 1 (RIPK1) and TRAF2 in liver parenchymal cells promoted the development of HCC [15], suggesting an active role of TRAF2. The gene discussed is TRAF2; the disease is hepatocellular carcinoma.